Juvenile myelomonocytic leukemia (JMML), accounting for around 2% of pediatric leukemia, is driven by mutations in the RAS pathway genes, with additional alterations in JAK/STAT signaling and in epigenetic modifier genes contributing to the leukemogenesis. Here, SOAT1 is linked to juvenile myelomonocytic leukemia.